The Safety and Efficacy of AVI Stent for Treating Coronary Revascularization

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.

Also called NCT02117843

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,200 participants (planned count) (from the registry)
Sponsor
Beijing AmsinoMed Medical Device Co., Ltd (from the registry)
Registry
  • NCT NCT02117843
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02117843. Allocation not applicable; no masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization
Condition
Ischemic Heart Disease
Condition
Myocardial Ischemia
Condition
Coronary Disease
Condition
Acute Coronary Syndrome
Intervention (Device)
AVI® Arsenic trioxide drug eluting stent
Lead sponsor
Beijing AmsinoMed Medical Device Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct02117843
Content hash
885ab549eda114fea1d85337bb3d4cd564359b30829e2f799c77f99491e6a83f